Commonwealth Equity Services’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.56M Sell
39,382
-1,763
-4% -$162K 0.01% 1580
2025
Q4
$3.7M Buy
41,145
+4,541
+12% +$431K ﹤0.01% 1535
2025
Q3
$3.61M Sell
36,604
-3,780
-9% -$375K ﹤0.01% 1582
2025
Q2
$3.68M Sell
40,384
-13,407
-25% -$1.3M ﹤0.01% 1545
2025
Q1
$6.09M Sell
53,791
-2,504
-4% -$268K 0.01% 1162
2024
Q4
$5.95M Sell
56,295
-2,214
-4% -$238K 0.01% 1137
2024
Q3
$6.32M Sell
58,509
-40
-0.1% -$4.37K 0.01% 1076
2024
Q2
$6.35M Sell
58,549
-6,293
-10% -$742K 0.01% 1050
2024
Q1
$8.56M Buy
64,842
+798
+1% +$99.7K 0.01% 868
2023
Q4
$7.79M Sell
64,044
-3,707
-5% -$414K 0.01% 856
2023
Q3
$7.6M Buy
67,751
+324
+0.5% +$41.1K 0.02% 806
2023
Q2
$9.82M Buy
67,427
+215
+0.3% +$29.2K 0.02% 689
2023
Q1
$8.68K Buy
67,212
+3,973
+6% +$499K 0.02% 731
2022
Q4
$8.06M Sell
63,239
-5,287
-8% -$614K 0.02% 729
2022
Q3
$7.16M Sell
68,526
-511
-0.7% -$56.1K 0.02% 729
2022
Q2
$7.25M Buy
69,037
+103
+0.1% +$12.2K 0.02% 721
2022
Q1
$8.82M Sell
68,934
-5,494
-7% -$662K 0.02% 673
2021
Q4
$9.18M Sell
74,428
-6,784
-8% -$888K 0.02% 632
2021
Q3
$11.5M Buy
81,212
+311
+0.4% +$45.7K 0.03% 522
2021
Q2
$12.6M Buy
80,901
+1,118
+1% +$181K 0.03% 483
2021
Q1
$12.4M Buy
79,783
+1,401
+2% +$217K 0.04% 447
2020
Q4
$11.7M Buy
78,382
+7,069
+10% +$998K 0.04% 429
2020
Q3
$9.43M Buy
71,313
+8,237
+13% +$1.08M 0.03% 455
2020
Q2
$7.31M Buy
63,076
+16,096
+34% +$1.85M 0.03% 502
2020
Q1
$4.61M Sell
46,980
-5,313
-10% -$696K 0.02% 581
2019
Q4
$7.6M Buy
52,293
+4,348
+9% +$600K 0.03% 486
2019
Q3
$6.39M Buy
47,945
+3,612
+8% +$467K 0.03% 517
2019
Q2
$5.07M Buy
44,333
+791
+2% +$92.6K 0.02% 571
2019
Q1
$5.4M Buy
43,542
+2,235
+5% +$254K 0.02% 527
2018
Q4
$4.16M Buy
41,307
+224
+0.5% +$25.2K 0.02% 554
2018
Q3
$5.24M Sell
41,083
-1,346
-3% -$160K 0.03% 523
2018
Q2
$4.59M Sell
42,429
-1,334
-3% -$145K 0.02% 538
2018
Q1
$4.63M Buy
43,763
+982
+2% +$114K 0.03% 505
2017
Q4
$5.01M Buy
42,781
+8,222
+24% +$930K 0.03% 475
2017
Q3
$3.93M Buy
34,559
+942
+3% +$109K 0.02% 528
2017
Q2
$4.19M Buy
33,617
+805
+2% +$95.4K 0.03% 496
2017
Q1
$3.89M Buy
32,812
+2,158
+7% +$245K 0.03% 508
2016
Q4
$3.07M Sell
30,654
-1,764
-5% -$189K 0.02% 551
2016
Q3
$4.09M Sell
32,418
-2,039
-6% -$252K 0.03% 427
2016
Q2
$4.03M Buy
34,457
+3,857
+13% +$437K 0.03% 419
2016
Q1
$3.17M Sell
30,600
-7,648
-20% -$740K 0.03% 475
2015
Q4
$3.81M Buy
38,248
+3,800
+11% +$372K 0.04% 409
2015
Q3
$3.14M Sell
34,448
-1,351
-4% -$135K 0.03% 449
2015
Q2
$3.8M Buy
35,799
+2,082
+6% +$230K 0.04% 409
2015
Q1
$3.85M Buy
33,717
+941
+3% +$107K 0.04% 406
2014
Q4
$3.61M Buy
32,776
+3,044
+10% +$321K 0.04% 389
2014
Q3
$2.9M Buy
29,732
+5,612
+23% +$552K 0.04% 426
2014
Q2
$2.43M Buy
24,120
+377
+2% +$36.8K 0.03% 490
2014
Q1
$2.18M Sell
23,743
-888
-4% -$81.8K 0.03% 491
2013
Q4
$2.23M Sell
24,631
-1,302
-5% -$113K 0.03% 461
2013
Q3
$2.07M Buy
25,933
+2,061
+9% +$162K 0.03% 440
2013
Q2
$1.74M Buy
+23,872
New +$1.78M 0.03% 460

Other funds holding ZBH

Commonwealth Equity Services's ZBH Position: Q1 2026 in Review

Commonwealth Equity Services reduced its Zimmer Biomet (ZBH) stake by 4.3% in Q1 2026, selling an estimated $162K and leaving 39,382 shares worth $3.56M. The position accounts for 0.01% of the portfolio, ranked #1580.

Commonwealth Equity Services first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.6M in Q2 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Commonwealth Equity Services held 39,382 shares of Zimmer Biomet worth $3.56M as of Q1 2026.
  • Commonwealth Equity Services sold 1,763 Zimmer Biomet shares in Q1 2026, an estimated $162K.
  • Zimmer Biomet made up 0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #1580 holding.
  • Commonwealth Equity Services first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
  • Commonwealth Equity Services's Zimmer Biomet position peaked at $12.6M in Q2 2021.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.